Bronchial reactivity and fractional exhaled NO in Crohn's disease in the era of immunomodulating treatment

Article · June 2012with11 Reads
DOI: 10.1111/j.1651-2227.2012.02751.x · Source: PubMed
  • Aaron Lerner at Carmel Medical Center, B.rappaport School of Medicine,Technion - Israel Institute of Technology, Haifa, Israel.
    • 38.57
    • Carmel Medical Center, B.rappaport School of Medicine,Technion - Israel Institute of Technology, Haifa, Israel.
  • Fahed Hakim at University of Chicago
    • 33.17
    • University of Chicago
  • Lea Bentur at Technion - Israel Institute of Technology
    • 41.8
    • Technion - Israel Institute of Technology
Our aim was to determine bronchial hyper-responsiveness (BHR) and fractional exhaled NO (FeNO) in a cohort followed and treated for Crohn's disease (CD) in a Pediatric Gastroenterology Unit. Consecutive children with CD were referred to the Pediatric Pulmonary Unit. Each patient completed a questionnaire, followed by spirometry, methacholine challenge test (MCT) and determination of FeNO. The control group included patients evaluated for functional cough who had negative MCT. Twenty-three children and young adults (mean age, 17.39 ± 2.96 years) with CD were compared to 24 healthy controls. 20/23 patients received immunomodulating treatment. Forced expiratory volume in 1 sec (FEV1) was significantly lower prior to (93.74 ± 10.81%, p = 0.009) and at the end of (78.91 ± 18.39%, p = 0.001) the MCT in the CD group compared with the control group (102.2 ± 10.477% and 95.33 ± 11.075%, respectively). Bronchial hyper-responsiveness was observed in 30.4% of patients with CD. FeNO levels were 15.37 ± 24.17 in CD and 11.38 ± 5.42 in the control group (p = 0.21). Neither the response to MCT nor FeNO levels were affected by the disease duration or activity index. In our series, BHR is less frequent than previously described in children with CD. We hypothesize that our finding could result from immunomodulating treatments or lower disease activity.
April 2012 · Respiratory medicine · Impact Factor: 3.09
    Since extraintestinal sites of inflammation have been demonstrated in patients with Crohn's disease (CD) and ulcerative colitis (UC), both entities are regarded as systemic disorders. There are only scarce data on the prevalence of inflammatory bowel disease (IBD)-associated lung involvement in children. The aim of our study was to investigate pulmonary involvement in pediatric patients with... [Show full abstract]
    February 2003 · Respiration · Impact Factor: 2.59
      Despite the known systemic manifestations of inflammatory bowel disease (IBD) and a large number of reports associating lung disease and IBD, the frequency of atopy and bronchial hyperreactivity (BHR) in IBD remains obscure. The aim of this study was to investigate the prevalence of abnormal pulmonary function tests, BHR and the atopic status in patients with IBD. Thirty patients with IBD (19... [Show full abstract]
      April 2010 · Inflammatory Bowel Diseases · Impact Factor: 4.46
        Pulmonary involvement due to inflammatory bowel disease (IBD) is frequent when evaluating a patient with IBD and pulmonary involvement remains complicated. Most of the patients are asymptomatic and the methods used are mostly invasive or expensive procedures. The aim of this prospective study is to evaluate the value of the fractional exhaled nitric oxide (FE(NO)) level for the diagnosis of... [Show full abstract]
        Conference Paper
        October 2010 · Journal of Asthma · Impact Factor: 1.80
          Background / Purpose: A technically correct, forced vital capacity maneuver may not be established in a large proportion of young children due to abrupt cessation of exhalation. The latter, precludes the use of flow-dependent vital capacity indices. The functional residual capacity (FRC) volume is situated at low lung volumes and is independent of the vital capacity endpoint.To examine the... [Show full abstract]
          February 2006 · BMC Pulmonary Medicine · Impact Factor: 2.40
            Symptomatic respiratory tract involvement is not common in Crohn's disease. Upper-airway obstruction has been reported before in Crohn's disease and usually responds well to steroid treatment. We report a case of a 32-year old patient with Crohn's disease who presented with progressively worsening dyspnea on exertion. Magnetic Resonance Imaging of the chest and bronchoscopy revealed severe... [Show full abstract]
            Discover more